Kimberly Page, PhD, MPH

SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address1001 Potrero Ave
San Francisco CA 94110
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Page is a Professor in Residence in the Department of Epidemiology and Biostatistics, Division of Infectious Disease, in the Department of Medicine at University of California San Francisco (UCSF). She is located with the Global Health Sciences group. She holds joint appointments in the Department of Medicine, Center for AIDS Prevention Studies (CAPS), in the Department of Orofacial Sciences in the School of Dentistry at UCSF and at the San Francisco Veteran's Administration Medical Center (SFVAMC) Department of Medicine, Division of Gastroenterology. She received her Ph.D and MPH from the University of California at Berkeley and completed fellowships at the UCSF Center for AIDS Prevention Studies and the Municipal Health Service in Amsterdam, the Netherlands. She has been the PI of multiple NIH and CDC funded grants, and collaborates with researchers nationally and internationally. Dr. Page is an infectious disease epidemiologist; her research is principally focused on HIV and hepatitis C virus (HCV) infections, principally prevention, natural history, and intervention research in marginalized and underserved populations including injection drug users, and female sex workers. She is currently leading a clinical trial testing a prophylactic HCV vaccine in active injection drug users and a large implementation science trial in Cambodia to reduce drug use and HIV infection in female sex workers. She is the PI of two NIH NIDA funded studies of of HIV and HCV including: the UFO Study, an internationally recognized study of acute HCV in young adult injection drug users, and, the InC3 Collaborative, which brings together investigators and data from preeminent prospective studies of HIV and HCV globally. Dr. Page has been a faculty lead, as Director of Latin and Central America Region for the Fogarty funded International Traineeships in AIDS Prevention Studies (ITAPS) program at UCSF since 2002, providing training and capacity building to scientists from developing countries including Brazil, Argentina, Peru, Guatemala, Mexico, and from Southeast Asia, including Cambodia and Thailand. To learn more about Dr. Page please visit the links below.

    Collapse keywords

    Collapse Research 
    Collapse Research Activities and Funding
    Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico
    CDC/NCHHSTP U18PS004568Sep 30, 2014 - Sep 29, 2017
    Role: Principal Investigator
    Cambodia Integrated HIV and Drug Prevention Implementation Program
    NIH/NIDA R01DA033672May 15, 2012 - Apr 30, 2017
    Role: Co-Principal Investigator
    International Collaborative of prospective studies of HIV and Hepatitis in IDU
    NIH/NIDA R01DA031056May 15, 2011 - Apr 30, 2016
    Role: Principal Investigator
    Culture and HIV Prevention in Cambodia
    NIH/NINR R01NR010995Jan 1, 2009 - Jun 30, 2012
    Role: Principal Investigator
    CDC/NCHHSTP U54PS001264Sep 30, 2008 - Sep 29, 2013
    Role: Principal Investigator
    ATS Use &HIV Among Young Female Sex and Entertainment Workers in Cambodia
    NIH/NIDA R21DA025441Jul 1, 2008 - Jun 30, 2009
    Role: Principal Investigator
    Phase 1/2 trial of Pharmacological HIV-1 Prevention
    NIH/NIAID U01AI054241Sep 15, 2003 - Jun 30, 2007
    Role: Principal Investigator
    HCV Infection &Treatment in Parolees: Feasibility Study
    NIH/NIDDK R03DK065113Sep 1, 2003 - Aug 31, 2006
    Role: Principal Investigator
    Acute Hepatitis C Infection in Young Injectors
    NIH/NIDA R01DA016017Sep 25, 2002 - Aug 31, 2019
    Role: Principal Investigator
    NIH/NIDCR R01DE012911Apr 15, 1999 - Mar 31, 2004
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Presentations
    Collapse Global Health
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Selected Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Page K, Bacon O. Commitment issues: PrEP adherence in injecting drug users. Lancet HIV. 2016 Nov 17. PMID: 27866872.
      View in: PubMed
    2. Asher AK, Portillo CJ, Cooper BA, Dawson-Rose C, Vlahov D, Page KA. Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs. Subst Use Misuse. 2016 Jul 28; 51(9):1218-23. PMID: 27219274.
      View in: PubMed
    3. Couture MC, Page K, Sansothy N, Stein E, Vun MC, Hahn JA. High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia. Drug Alcohol Depend. 2016 Aug 1; 165:29-37. PMID: 27251102.
      View in: PubMed
    4. Page K, Stein ES, Carrico AW, Evans JL, Sokunny M, Nil E, Ngak S, Sophal C, McCulloch C, Maher L. Protocol of a cluster randomised stepped-wedge trial of behavioural interventions targeting amphetamine-type stimulant use and sexual risk among female entertainment and sex workers in Cambodia. BMJ Open. 2016; 6(5):e010854. PMID: 27160844.
      View in: PubMed
    5. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. Am J Public Health. 2016 May; 106(5):915-7. PMID: 26985620.
      View in: PubMed
    6. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. PMID: 26973850.
      View in: PubMed
    7. Draughon Moret JE, Carrico AW, Evans JL, Stein ES, Couture MC, Maher L, Page K. The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2016 Apr 1; 161:171-7. PMID: 26883684.
      View in: PubMed
    8. Carrico AW, Nil E, Sophal C, Stein E, Sokunny M, Yuthea N, Evans JL, Ngak S, Maher L, Page K. Behavioral interventions for Cambodian female entertainment and sex workers who use amphetamine-type stimulants. J Behav Med. 2016 Jun; 39(3):502-10. PMID: 26782667.
      View in: PubMed
    9. Dixon TC, Ngak S, Stein E, Carrico A, Page K, Maher L. Pharmacology, physiology and performance: occupational drug use and HIV risk among female entertainment and sex workers in Cambodia. Harm Reduct J. 2015; 12:33. PMID: 26472570; PMCID: PMC4608294.
    10. El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release. J Virol. 2015 Sep; 89(18):9454-64. PMID: 26157120; PMCID: PMC4542372 [Available on 03/15/16].
    11. Siddiqui SS, Armenta RF, Evans JL, Yu M, Cuevas-Mota J, Page K, Davidson P, Garfein RS. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Int J Drug Policy. 2015 Nov; 26(11):1150-7. PMID: 26252980; PMCID: PMC4581911 [Available on 11/01/16].
    12. Maher L, Dixon T, Phlong P, Mooney-Somers J, Stein E, Page K. Conflicting Rights: How the Prohibition of Human Trafficking and Sexual Exploitation Infringes the Right to Health of Female Sex Workers in Phnom Penh, Cambodia. Health Hum Rights. 2015; 17(1):E102-13. PMID: 26204575.
      View in: PubMed
    13. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection-the InC3 Study. J Infect Dis. 2015 Nov 1; 212(9):1407-19. PMID: 25883387; PMCID: PMC4601911 [Available on 11/01/16].
    14. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One. 2015; 10(4):e0122232. PMID: 25837807; PMCID: PMC4383375.
    15. Wadhera P, Evans JL, Stein E, Gandhi M, Couture MC, Sansothy N, Sichan K, Maher L, Kaldor J, Page K, Kaldor J, Kien SP, Page K, Palefsky JM, Saphonn V, Vun MC. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study. Int J STD AIDS. 2015 Oct; 26(12):893-902. PMID: 25505042; PMCID: PMC4506266.
    16. Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014 Dec; 174(12):1974-81. PMID: 25347412; PMCID: PMC4506774.
    17. Vickerman P, Page K, Maher L, Hickman M. Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base? Addiction. 2014 Dec; 109(12):2060-1. PMID: 25384936; PMCID: PMC4520398.
    18. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. PMID: 25286346; PMCID: PMC4186818.
    19. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol. 2014 Nov; 61(3):430-4. PMID: 25256151; PMCID: PMC4279031.
    20. White B, Madden A, Prins M, Hellard M, Wand H, Dore GJ, Page K, Maher L. Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study. Vaccine. 2014 Sep 22; 32(42):5460-7. PMID: 25131726; PMCID: PMC4509604.
    21. Evans JL, Morris MD, Yu M, Page K, Hahn JA. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Sep 1; 142:239-44. PMID: 25034898; PMCID: PMC4471952.
    22. Hayes B, Briceno A, Asher A, Yu M, Evans JL, Hahn JA, Page K. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health. 2014; 14:645. PMID: 24965699; PMCID: PMC4091768.
    23. Jain J, Evans JL, Briceño A, Page K, Hahn JA. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol. 2014 Sep-Oct; 49(5):520-4. PMID: 24939855; PMCID: PMC4128670.
    24. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014; 4(5):e004988. PMID: 24875490; PMCID: PMC4039809.
    25. Grebely J, Dore GJ, Kim AY, Lloyd A, Shoukry NH, Prins M, Page K. Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. Hepatology. 2014 Dec; 60(6):2127-8. PMID: 24715633; PMCID: PMC4192101 [Available on 12/01/15].
    26. Grebely J, Grady B, Hajarizadeh B, Page K, Dore GJ. Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels? Hepatology. 2014 Apr; 59(4):1650-1. PMID: 23929769; PMCID: PMC3918244.
    27. Dokubo EK, Evans J, Winkelman V, Cyrus S, Tobler LH, Asher A, Briceno A, Page K. Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens. J Clin Virol. 2014 Apr; 59(4):223-7. PMID: 24529844; PMCID: PMC4026019.
    28. Inglez-Dias A, Ribeiro JM, Bastos FI, Page K. [Harm reduction policies in Brazil: contributions of a North American program]. Cien Saude Colet. 2014 Jan; 19(1):147-57. PMID: 24473612.
      View in: PubMed
    29. Ikeda JM, Tellez CA, Hudes ES, Page K, Evans J, Racancoj O, Hearst N. Impact of integrating HIV and TB care and treatment in a regional tuberculosis hospital in rural Guatemala. AIDS Behav. 2014 Jan; 18 Suppl 1:S96-103. PMID: 23959143.
      View in: PubMed
    30. Silveira MP, Guttier MC, Page K, Moreira LB. Randomized controlled trial to evaluate the impact of pharmaceutical care on therapeutic success in HIV-infected patients in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S75-84. PMID: 23975474.
      View in: PubMed
    31. Miranda AE, Pinto VM, McFarland W, Page K. HIV infection among young pregnant women in Brazil: prevalence and associated risk factors. AIDS Behav. 2014 Jan; 18 Suppl 1:S50-2. PMID: 23754614; PMCID: PMC3818388.
    32. Callegari FM, Pinto-Neto LF, Medeiros CJ, Scopel CB, Page K, Miranda AE. Syphilis and HIV co-infection in patients who attend an AIDS outpatient clinic in Vitoria, Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S104-9. PMID: 23732958; PMCID: PMC3818508.
    33. Silveira MP, Guttier MC, Moreira LB, Mirzazadeh A, Page K. Predictors of non-adherence to clinical follow-up among patients participating in a randomized trial of pharmaceutical care intervention in HIV-positive adults in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S85-8. PMID: 23955660.
      View in: PubMed
    34. Ikeda JM, Schaffer JR, Sac Ixcot ML, Page K, Hearst N. Risk of sexually transmitted infections among Mayan women in rural Guatemala whose partners are migrant workers. AIDS Behav. 2014 Jan; 18 Suppl 1:S32-6. PMID: 23963499.
      View in: PubMed
    35. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. PMID: 23908124; PMCID: PMC3972017.
    36. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6. PMID: 23939233; PMCID: PMC4125012.
    37. Kim AY, Page K. Hepatitis C virus serosorting in people who inject drugs: sorting out the details. J Infect Dis. 2013 Dec 15; 208(12):1929-31. PMID: 24136791; PMCID: PMC3836470.
    38. Page K, Stein E, Sansothy N, Evans J, Couture MC, Sichan K, Cockroft M, Mooney-Somers J, Phlong P, Kaldor J, Maher L. Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open. 2013; 3(9):e003095. PMID: 24022389; PMCID: PMC3773643.
    39. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. PMID: 23884063; PMCID: PMC3722077.
    40. Page K, Morris MD, Hahn JA, Maher L, Prins M. Clinical Infectious Diseases. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. 2013; S2(57):32-38.
    41. Pinto Neto LF, das Neves MB, Ribeiro-Rodrigues R, Page K, Miranda AE. Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic. Braz J Infect Dis. 2013 Jul-Aug; 17(4):438-43. PMID: 23735423.
      View in: PubMed
    42. Evans JL, Couture MC, Stein ES, Sansothy N, Maher L, Page K. Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia. Sex Transm Dis. 2013 Jun; 40(6):462-8. PMID: 23680902; PMCID: PMC3891890.
    43. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. J Urban Health. 2013 Jun; 90(3):500-15. PMID: 22744293; PMCID: PMC3665972.
    44. Blatyta PF, Custer B, Gonçalez TT, Birch R, Lopes ME, Lopes Ferreira MI, Carneiro Proietti AB, Sabino EC, Page K, de Almeida-Neto C. Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil. Transfusion. 2013 Nov; 53(11):2734-43. PMID: 23521083; PMCID: PMC3708980.
    45. Maher L, Mooney-Somers J, Phlong P, Couture MC, Kien SP, Stein E, Bates AJ, Sansothy N, Page K. Condom negotiation across different relationship types by young women engaged in sex work in Phnom Penh, Cambodia. Glob Public Health. 2013; 8(3):270-83. PMID: 23432108; PMCID: PMC3729959.
    46. Etcheverry MF, Evans JL, Sanchez E, Mendez-Arancibia E, Meroño M, Gatell JM, Page K, Joseph J. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Hum Vaccin Immunother. 2013 Feb; 9(2):420-9. PMID: 23291931; PMCID: PMC3859767.
    47. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol. 2013 Dec; 42(6):1649-59. PMID: 23203695; PMCID: PMC3887561.
    48. Asher AK, Hahn JA, Couture MC, Maher K, Page K. people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013 Nov-Dec; 24(6):e35-44. PMID: 23164598; PMCID: PMC3800507.
    49. White B, Madden A, Hellard M, Kerr T, Prins M, Page K, Dore GJ, Maher L. Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug Alcohol Rev. 2013 Jul; 32(4):419-25. PMID: 23113829; PMCID: PMC3567229.
    50. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13. PMID: 23090930; PMCID: PMC3540042.
    51. Brown C, Krishnan S, Hursh K, Yu M, Johnson P, Page K, Shiboski CH. Dental disease prevalence among methamphetamine and heroin users in an urban setting: a pilot study. J Am Dent Assoc. 2012 Sep; 143(9):992-1001. PMID: 22942146; PMCID: PMC3729940.
    52. Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis. 2012; 12:166. PMID: 22839728; PMCID: PMC3436768.
    53. Wang Z, Du J, Zhao M, Page K, Xiao Z, Mandel JS. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. Asia Pac Psychiatry. 2013 Sep; 5(3):191-6. PMID: 23857926; PMCID: PMC4513657.
    54. Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013 Jan 1; 127(1-3):143-9. PMID: 22819868; PMCID: PMC3762448.
    55. Kab V, Evans J, Sansothy N, Stein E, Claude-Couture M, Maher L, Page K. Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia. Addict Sci Clin Pract. 2012; 7:11. PMID: 23186171; PMCID: PMC3507647.
    56. Davidson P, Page K. Research participation as work: comparing the perspectives of researchers and economically marginalized populations. Am J Public Health. 2012 Jul; 102(7):1254-9. PMID: 22594754; PMCID: PMC3478002.
    57. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14. PMID: 22541630; PMCID: PMC3608418.
    58. Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M. The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. J Infect Dis. 2012 May 1; 205(9):1342-50. PMID: 22457292; PMCID: PMC3324399.
    59. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8. PMID: 22227793; PMCID: PMC3271816.
    60. Miranda AE, Figueiredo NC, Pinto VM, Page K, Talhari S. Risk factors for syphilis in young women attending a family health program in Vitória, Brazil. An Bras Dermatol. 2012 Jan-Feb; 87(1):76-83. PMID: 22481654.
      View in: PubMed
    61. Maher L, Mooney-Somers J, Phlong P, Couture MC, Stein E, Evans J, Cockroft M, Sansothy N, Nemoto T, Page K. Selling sex in unsafe spaces: sex work risk environments in Phnom Penh, Cambodia. Harm Reduct J. 2011; 8:30. PMID: 22099449.
      View in: PubMed
    62. Pinho AA, Chinaglia M, Lippman SA, Reingold A, Diaz RS, Sucupira MC, Page K, Díaz J. Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border. Sex Transm Infect. 2011 Dec; 87(7):553-9. PMID: 21968460; PMCID: PMC4539241.
    63. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb; 64(2):97-109. PMID: 21898189; PMCID: PMC4143378.
    64. Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, Page K. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2012 Jan 1; 120(1-3):119-26. PMID: 21820251; PMCID: PMC3226861.
    65. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011; 11:208. PMID: 21810243; PMCID: PMC3199778.
    66. Bahia F, Novais V, Evans J, Le Marchand C, Netto E, Page K, Brites C. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011 Aug; 57 Suppl 3:S202-7. PMID: 21857319; PMCID: PMC3747031.
    67. Asher A, Lum PJ, Page K. Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report. J Assoc Nurses AIDS Care. 2012 Jan-Feb; 23(1):16-29. PMID: 21497111; PMCID: PMC3140618.
    68. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011 May; 22(3):203-9. PMID: 21316935; PMCID: PMC3104095.
    69. Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, Sierra E, Gatell JM, Page K, Joseph J. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine. 2011 Feb 24; 29(10):1991-6. PMID: 21241735; PMCID: PMC3747033.
    70. Couture MC, Sansothy N, Sapphon V, Phal S, Sichan K, Stein E, Evans J, Maher L, Kaldor J, Vun MC, Page K. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis. 2011 Jan; 38(1):33-9. PMID: 21085056; PMCID: PMC3729941.
    71. Maher L, White B, Hellard M, Madden A, Prins M, Kerr T, Page K. Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine. 2010 Oct 21; 28(45):7273-8. PMID: 20831914; PMCID: PMC3729933.
    72. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51. PMID: 20638453; PMCID: PMC2936506.
    73. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64. PMID: 20491725; PMCID: PMC2907461.
    74. Sarang A, Rhodes T, Sheon N, Page K. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse. 2010 May; 45(6):813-64. PMID: 20397872; PMCID: PMC2946846.
    75. Berini CA, Gendler SA, Pascuccio S, Eirin ME, McFarland W, Page K, Carnevali L, Murphy E, Biglione MM. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J Med Virol. 2010 May; 82(5):873-7. PMID: 20336721.
      View in: PubMed
    76. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26. PMID: 19764883; PMCID: PMC2821203.
    77. Miranda AE, St Louis ME, Figueiredo NC, Milbratz I, Page-Shafer K. Young women and their reproductive health needs in a family practice setting: factors influencing care seeking in Vitoria, Brazil. Fam Pract. 2009 Dec; 26(6):493-500. PMID: 19770219; PMCID: PMC2791044.
    78. Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depend. 2009 Nov 1; 105(1-2):160-3. PMID: 19647375; PMCID: PMC2849721.
    79. Levy V, Yuan J, Ruiz J, Morrow S, Reardon J, Facer M, Molitor F, Allen B, Ajufo BG, Bell-Sanford G, McFarland W, Raymond HF, Kellogg T, Page K. Hepatitis B sero-prevalence and risk behaviors among immigrant men in a population-based household survey in low-income neighborhoods of northern California. J Immigr Minor Health. 2010 Dec; 12(6):828-33. PMID: 19319680; PMCID: PMC2964463.
    80. Hahn JA, Wylie D, Dill J, Sanchez MS, Lloyd-Smith JO, Page-Shafer K, Getz WM. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics. 2009 Mar; 1(1):47-57. PMID: 20445816.
      View in: PubMed
    81. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009 May 1; 101(3):152-7. PMID: 19181458; PMCID: PMC2692897.
    82. Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology. 2009 Jan; 136(1):26-31. PMID: 19059257; PMCID: PMC4143376.
    83. Figueiredo NC, Page-Shafer K, Pereira FE, Miranda AE. [Serological markers for hepatitis B virus in young women attended by the Family Health Program in Vitória, Espírito Santo, 2006]. Rev Soc Bras Med Trop. 2008 Nov-Dec; 41(6):590-5. PMID: 19142438.
      View in: PubMed
    84. Sampaio-Sa M, Page-Shafer K, Bangsberg DR, Evans J, Dourado Mde L, Teixeira C, Netto EM, Brites C. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S54-62. PMID: 18512141.
      View in: PubMed
    85. Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D, Ramos M, Brites C. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008 Jul; 12(4 Suppl):S17-24. PMID: 18500658.
      View in: PubMed
    86. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91. PMID: 18368610; PMCID: PMC3747037.
    87. Miranda AE, Figueiredo NC, Schmidt R, Page-Shafer K. A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S25-31. PMID: 18401700.
      View in: PubMed
    88. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36. PMID: 18233994.
      View in: PubMed
    89. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008 Jan 1; 197(1):126-33. PMID: 18171295; PMCID: PMC3466592.
    90. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol. 2008 Feb; 46(2):499-506. PMID: 18032621; PMCID: PMC2238141.
    91. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):43-50. PMID: 17980513; PMCID: PMC2247437.
    92. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007 Sep 12; 21(14):1967-9. PMID: 17721105.
      View in: PubMed
    93. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology. 2007 Sep 1; 365(2):446-56. PMID: 17493654; PMCID: PMC2001282.
    94. Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007 Feb; 21(2):116-28. PMID: 17328661.
      View in: PubMed
    95. Levy V, Prentiss D, Balmas G, Chen S, Israelski D, Katzenstein D, Page-Shafer K. Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs. J Immigr Minor Health. 2007 Jan; 9(1):49-54. PMID: 17031578.
      View in: PubMed
    96. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. Absence of HCV viral recombination following superinfection. J Viral Hepat. 2006 Aug; 13(8):532-7. PMID: 16901283.
      View in: PubMed
    97. de Carvalho FT, Neiva-Silva L, Ramos MC, Evans J, Koller SH, Piccinini CA, Page-Shafer K. Sexual and drug use risk behaviors among children and youth in street circumstances in Porto Alegre, Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S57-66. PMID: 16845605.
      View in: PubMed
    98. Telles Dias PR, Souto K, Page-Shafer K. Long-term female condom use among vulnerable populations in Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S67-75. PMID: 16799843.
      View in: PubMed
    99. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. PMID: 16565643.
      View in: PubMed
    100. Page-Shafer K, Sweet S, Kassaye S, Ssali C. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res. 2006; 19(1):152-7. PMID: 16672566.
      View in: PubMed
    101. Kim AA, Sun LP, Chhorvann C, Lindan C, Van Griensven F, Kilmarx PH, Sirivongrangson P, Louie JK, Leng HB, Page-Shafer K. High prevalence of HIV and sexually transmitted infections among indirect sex workers in Cambodia. Sex Transm Dis. 2005 Dec; 32(12):745-51. PMID: 16314771.
      View in: PubMed
    102. Cohan DL, Kim A, Ruiz J, Morrow S, Reardon J, Lynch M, Klausner JD, Molitor F, Allen B, Green Ajufo B, Ferrero D, Bell Sanford G, Page-Shafer K, Delgado V, McFarland W. Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey. Sex Transm Infect. 2005 Oct; 81(5):428-33. PMID: 16199746; PMCID: PMC1745033.
    103. Page-Shafer K, Saphonn V, Sun LP, Vun MC, Cooper DA, Kaldor JM. HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet. 2005 Oct 22-28; 366(9495):1499-503. PMID: 16243095.
      View in: PubMed
    104. Levy V, Page-Shafer K, Evans J, Ruiz J, Morrow S, Reardon J, Lynch M, Raymond HF, Klausner JD, Facer M, Molitor F, Allen B, Ajufo BG, Ferrero D, Sanford GB, McFarland W. HIV-related risk behavior among Hispanic immigrant men in a population-based household survey in low-income neighborhoods of northern California. Sex Transm Dis. 2005 Aug; 32(8):487-90. PMID: 16041250.
      View in: PubMed
    105. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005 Dec 12; 80(3):297-302. PMID: 15961257.
      View in: PubMed
    106. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86. PMID: 15983913.
      View in: PubMed
    107. Busch MP, Shafer KA. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis. 2005 Apr 1; 40(7):959-61. PMID: 15824986.
      View in: PubMed
    108. Kral AH, Page-Shafer K, Edlin BR, Kellogg T, Riley E, Gee L, Moss A, Busch M, Klausner JD, Dilley J, McFarland W. Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr. 2004 Dec 15; 37(5):1667-9. PMID: 15577428.
      View in: PubMed
    109. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis. 2004 Oct 15; 190(8):1396-403. PMID: 15378431.
      View in: PubMed
    110. Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis. 2004 Sep; 31(9):542-6. PMID: 15480115.
      View in: PubMed
    111. Samnang P, Leng HB, Kim A, Canchola A, Moss A, Mandel JS, Page-Shafer K. HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia. Int J STD AIDS. 2004 Jul; 15(7):479-83. PMID: 15228734.
      View in: PubMed
    112. Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL. Poorly soluble peptides can mimic authentic ELISPOT responses. J Immunol Methods. 2004 Feb 1; 285(1):89-92. PMID: 14871537.
      View in: PubMed
    113. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004 Jan 2; 18(1):81-8. PMID: 15090833; PMCID: PMC2442908.
    114. Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B, Williams I, Dilley J, Page-Shafer K, Klausner JD. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis. 2003 Dec; 30(12):919-24. PMID: 14646642.
      View in: PubMed
    115. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health. 2003 Jun; 93(6):919-23. PMID: 12773355; PMCID: PMC1447870.
    116. Turner KR, McFarland W, Kellogg TA, Wong E, Page-Shafer K, Louie B, Dilley J, Kent CK, Klausner J. Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis. 2003 Apr; 30(4):331-4. PMID: 12671554.
      View in: PubMed
    117. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46. PMID: 12612103; PMCID: PMC3456106.
    118. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003 Feb 8; 326(7384):308. PMID: 12574043; PMCID: PMC143525.
    119. Page-Shafer K, Shiboski CH, Osmond DH, Dilley J, McFarland W, Shiboski SC, Klausner JD, Balls J, Greenspan D, Greenspan JS. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS. 2002 Nov 22; 16(17):2350-2. PMID: 12441814.
      View in: PubMed
    120. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 1; 186(11):1558-64. PMID: 12447730.
      View in: PubMed
    121. Fernyak SE, Page-Shafer K, Kellogg TA, McFarland W, Katz MH. Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):63-70. PMID: 12352152.
      View in: PubMed
    122. Scheer S, Peterson I, Page-Shafer K, Delgado V, Gleghorn A, Ruiz J, Molitor F, McFarland W, Klausner J. Sexual and drug use behavior among women who have sex with both women and men: results of a population-based survey. Am J Public Health. 2002 Jul; 92(7):1110-2. PMID: 12084692; PMCID: PMC1447198.
    123. Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health. 2002 Apr; 92(4):670-6. PMID: 11919070; PMCID: PMC3222218.
    124. McCarthy GM, Ssali CS, Bednarsh H, Jorge J, Wangrangsimakul K, Page-Shafer K. Transmission of HIV in the dental clinic and elsewhere. Oral Dis. 2002; 8 Suppl 2:126-35. PMID: 12164646.
      View in: PubMed
    125. Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis. 2002; 8 Suppl 2:169-75. PMID: 12164652.
      View in: PubMed
    126. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis. 2002 Jan 15; 34(2):173-6. PMID: 11740704.
      View in: PubMed
    127. Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, Huitsing J, Barnes S, Clemente V, Chesney M. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001 Dec; 15(12):615-24. PMID: 11788076.
      View in: PubMed
    128. Moon MW, Binson D, Page-Shafer K, Díaz R. Correlates of HIV risk in a random sample of street youths in San Francisco. J Assoc Nurses AIDS Care. 2001 Nov-Dec; 12(6):18-27. PMID: 11723912.
      View in: PubMed
    129. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul; 34(1):180-7. PMID: 11431749.
      View in: PubMed
    130. Misegades L, Page-Shafer K, Halperin D, McFarland W. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS. 2001 Mar 9; 15(4):534-5. PMID: 11242155.
      View in: PubMed
    131. Greenwood GL, White EW, Page-Shafer K, Bein E, Osmond DH, Paul J, Stall RD. Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men's Health Study. Drug Alcohol Depend. 2001 Jan 1; 61(2):105-12. PMID: 11137274.
      View in: PubMed
    132. Rugg DL, Heitgerd JL, Cotton DA, Broyles S, Freeman A, Lopez-Gomez AM, Cotten-Oldenburg NU, Page-Shafer K. CDC HIV prevention indicators: monitoring and evaluating HIV prevention in the USA. AIDS. 2000 Sep 8; 14(13):2003-13. PMID: 10997406.
      View in: PubMed
    133. Page-Shafer K, Kim A, Norton P, Rugg D, Heitgerd J, Katz MH, McFarland W. Evaluating national HIV prevention indicators: a case study in San Francisco. AIDS. 2000 Sep 8; 14(13):2015-26. PMID: 10997407.
      View in: PubMed
    134. Buchacz K, McFarland W, Hernandez M, Klausner JD, Page-Shafer K, Padian N, Molitor F, Ruiz JD, Bolan G, Morrow S, Katz MH. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team. Sex Transm Dis. 2000 Aug; 27(7):393-400. PMID: 10949430.
      View in: PubMed
    135. Ruiz JD, Molitor F, McFarland W, Klausner J, Lemp G, Page-Shafer K, Parikh-Patel A, Morrow S, Sun RK. Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med. 2000 Jun; 172(6):368-73. PMID: 10854379; PMCID: PMC1070918.
    136. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol. 2000 Feb; 38(2):696-701. PMID: 10655369; PMCID: PMC86179.
    137. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998 Apr 2; 338(14):948-54. PMID: 9521982.
      View in: PubMed
    138. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee S, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol. 1997 Oct 1; 146(7):531-42. PMID: 9326430.
      View in: PubMed
    139. Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schechter MT, Coutinho RA, Keet IP, van Griensven GJ. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis. 1997 Jul; 176(1):112-7. PMID: 9207356.
      View in: PubMed
    140. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996 Sep; 6(5):420-30. PMID: 8915473.
      View in: PubMed
    141. Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven GJ, Coutinho RA. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS. 1996 Aug; 10(9):959-65. PMID: 8853728.
      View in: PubMed
    142. Chin DP, Osmond D, Page-Shafer K, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, Wallace JM, Poole WK, Hopewell PC. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1996 Jun; 153(6 Pt 1):1982-4. PMID: 8665065.
      View in: PubMed
    143. Veugelers PJ, Strathdee SA, Moss AR, Page KA, Tindall B, Schechter MT, Coutinho RA, van Griensven GJ. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. Epidemiology. 1995 Jul; 6(4):382-6. PMID: 7548345.
      View in: PubMed
    144. Osmond DH, Page K, Wiley J, Garrett K, Sheppard HW, Moss AR, Schrager L, Winkelstein W. HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health. 1994 Dec; 84(12):1933-7. PMID: 7998633; PMCID: PMC1615371.
    145. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein WW, Cooper DA, Craib KJ, Charlebois E, Coutinho RA. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol. 1994 Oct 15; 140(8):747-58. PMID: 7942776.
      View in: PubMed
    146. Veugelers PJ, Strathdee SA, Tindall B, Page KA, Moss AR, Schechter MT, Montaner JS, van Griensven GJ. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS. 1994 Oct; 8(10):1471-5. PMID: 7818819.
      View in: PubMed
    147. Veugelers PJ, Schechter MT, Tindall B, Moss AR, Page KA, Craib KJ, Cooper DA, Coutinho RA, Charlebois E, Winkelstein W. Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS. 1993 Oct; 7(10):1325-9. PMID: 7903540.
      View in: PubMed
    148. Lang W, Osmond D, Page-Bodkin K, Moss A, Winkelstein W. Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991. J Acquir Immune Defic Syndr. 1993 Feb; 6(2):191-5. PMID: 8381868.
      View in: PubMed
    149. Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan; 167(1):66-71. PMID: 8418184.
      View in: PubMed
    150. Page-Bodkin K, Tappero J, Samuel M, Winkelstein W. Kaposi's sarcoma and faecal-oral exposure. Lancet. 1992 Jun 13; 339(8807):1490. PMID: 1351178.
      View in: PubMed
    Kimberly's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP